Insider Cluster (2 insiders) ·Filed Jun 26, 2026

INSM

INSMED Inc
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $1.4M total
Actionable Insight • Neutral

This insider cluster is too small to warrant a trading response. Monitor for any material corporate events (earnings, pipeline updates) that could explain the sales, but the dollar amount is consistent with routine portfolio diversification.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
INSM ▲ +15.35% at T+60d
NEUTRAL call ✓ call won +15.35% · α vs SPY +10.97% · entry $104.74 → $120.82
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
+1.79%
call +1.79% · α +1.02%
$106.62
settled 3mo ago
T+5d
+6.49%
call +6.49% · α +5.11%
$111.54
settled 3mo ago
T+20d
+2.08%
call +2.08% · α +2.36%
$106.92
settled 2mo ago
T+60d
+15.35%
call +15.35% · α +10.97%
$120.82
settled 10d ago

Price Chart

Loading chart...

Executive Summary

Two INSM insiders, including the CEO, sold a combined $1.41M in shares over June 22-25, 2026. The total represents only ~0.006% of the company's $23.2B market cap, making this a routine and immaterial event with no bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.4M
Insiders
2

Key Facts

  • CEO Lewis William sold 12.1K shares at $102.34 for $1.24M on June 25, 2026
  • Chief Legal Officer Smith Michael Alexander sold 1.8K shares at $95.82 for $173K on June 22, 2026
  • Total insider sales of $1.41M represent ~0.006% of INSM's $23.2B market cap
  • Insider sales are weak predictors per academic literature, especially at this trivial scale
  • 97% of analysts rate INSM as Buy/Strong Buy, indicating strong fundamental sentiment

Financial Impact

Insider sales of $1.41M are negligible relative to $23.2B market cap

Risk Factors

  • Insider sales could accelerate if insiders perceive downside, but current scale is immaterial
  • Historical INSM reports have underperformed, suggesting caution on any bullish/bearish calls

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
97% bullish (29 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INSM-1783024936952
18 reports for INSM
Performance horizon
86% Hit rate 6 of 7 directional calls best @ T+60▲ +31.86%Mar 30, 2026
Filters
Rows
Reports for INSM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$130.66 $119.92▼ −8.22%▼ −6.70%$109.99 (−15.82%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$126.33 $129.41▲ +2.44%▲ +4.19%$109.99 (−12.93%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 8/10
$132.55 $126.68▼ −4.43%▼ −5.03%$109.99 (−17.02%)
Jul 24, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$106.92 $125.77▲ +17.63%▲ +14.00%$109.99 (+2.87%)
Jul 21, 2026
10w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$108.62 $128.46▲ +18.27%▲ +15.70%$109.99 (+1.26%)
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$107.46 $126.33▲ +17.56%▲ +13.94%$109.99 (+2.35%)
Jun 26, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$104.74 $106.92▲ +2.08%▲ +2.36%$109.99 (+5.01%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
Jun 5, 2026
16w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$109.99 (+16.80%)
May 15, 2026
19w ago
S-3ASR
NEUTRAL ★ 3/10
$107.15 $95.52▼ −10.85%▼ −12.44%$109.99 (+2.65%)
Showing 10 of 18

US Market Status

Market Open — Closes in 49m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 26, 2026